FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2529084725> ?p ?o ?g. }

• W2529084725 endingPage "52" @default.
• W2529084725 startingPage "45" @default.
• W2529084725 abstract "Objective To analyze bleeding-related complications among patients on long-term anticoagulation (AC) undergoing ureteroscopy (URS). Current American Urological Association/International Consultation on Urological Diseases guidelines state that it is safe to continue AC in routine URS; however, these recommendations are based on small case series. Patients and Methods There were 4799 identified URS procedures performed at our institution between June 2009 and February 2016. Records were then retrospectively reviewed to confirm AC use and identify periprocedural complications. Anticoagulant agents evaluated included warfarin, enoxaparin, and non-vitamin K antagonists (ie, rivaroxaban, dabigatran, apibaxan). Patients were excluded if they were taking a concurrent antiplatelet (AP) agent or if additional non-URS procedures were performed. Results Of the 4799 URS procedures, 272 (5.6%) were done on patients taking chronic AC. Of these, 193 (71%) held AC, 53 (19%) were bridged with enoxaparin, and 26 (10%) continued AC. The median age was 70.2 years and the majority of patients (64.2%) underwent a stone procedure with a stone-free rate of 73%. The overall bleeding-related complication rate was 8.1% whereas the significant bleeding-related event rate was 5.9%. Patients continuing AC had the highest significant bleeding-related event rate at 15.4% compared to 9% and 3% for those bridged with enoxaparin and those who held, respectively (P = .01). Conclusion Continuation or bridging of AC may increase the risk of perioperative bleeding. The risks and benefits of proceeding with URS on AC must be weighed carefully. Pending external validation, this information may be used for patient counseling and risk stratification. To analyze bleeding-related complications among patients on long-term anticoagulation (AC) undergoing ureteroscopy (URS). Current American Urological Association/International Consultation on Urological Diseases guidelines state that it is safe to continue AC in routine URS; however, these recommendations are based on small case series. There were 4799 identified URS procedures performed at our institution between June 2009 and February 2016. Records were then retrospectively reviewed to confirm AC use and identify periprocedural complications. Anticoagulant agents evaluated included warfarin, enoxaparin, and non-vitamin K antagonists (ie, rivaroxaban, dabigatran, apibaxan). Patients were excluded if they were taking a concurrent antiplatelet (AP) agent or if additional non-URS procedures were performed. Of the 4799 URS procedures, 272 (5.6%) were done on patients taking chronic AC. Of these, 193 (71%) held AC, 53 (19%) were bridged with enoxaparin, and 26 (10%) continued AC. The median age was 70.2 years and the majority of patients (64.2%) underwent a stone procedure with a stone-free rate of 73%. The overall bleeding-related complication rate was 8.1% whereas the significant bleeding-related event rate was 5.9%. Patients continuing AC had the highest significant bleeding-related event rate at 15.4% compared to 9% and 3% for those bridged with enoxaparin and those who held, respectively (P = .01). Continuation or bridging of AC may increase the risk of perioperative bleeding. The risks and benefits of proceeding with URS on AC must be weighed carefully. Pending external validation, this information may be used for patient counseling and risk stratification." @default.
• W2529084725 created "2016-10-14" @default.
• W2529084725 creator A5006595036 @default.
• W2529084725 creator A5008621850 @default.
• W2529084725 creator A5017941913 @default.
• W2529084725 creator A5038206854 @default.
• W2529084725 creator A5055494457 @default.
• W2529084725 creator A5090882064 @default.
• W2529084725 date "2017-02-01" @default.
• W2529084725 modified "2023-09-29" @default.
• W2529084725 title "The Effect of Anticoagulation on Bleeding-related Complications Following Ureteroscopy" @default.
• W2529084725 cites W1837600385 @default.
• W2529084725 cites W1913182214 @default.
• W2529084725 cites W1939082786 @default.
• W2529084725 cites W1982223025 @default.
• W2529084725 cites W2012154384 @default.
• W2529084725 cites W2013954102 @default.
• W2529084725 cites W2054436867 @default.
• W2529084725 cites W2062786076 @default.
• W2529084725 cites W2070680174 @default.
• W2529084725 cites W2071684395 @default.
• W2529084725 cites W2082050274 @default.
• W2529084725 cites W2089596110 @default.
• W2529084725 cites W2100561298 @default.
• W2529084725 cites W2114775432 @default.
• W2529084725 cites W2116775894 @default.
• W2529084725 cites W2129690852 @default.
• W2529084725 cites W2139208425 @default.
• W2529084725 cites W2147800731 @default.
• W2529084725 cites W2152653428 @default.
• W2529084725 cites W2153092895 @default.
• W2529084725 cites W2170497400 @default.
• W2529084725 cites W2332034563 @default.
• W2529084725 cites W2724431303 @default.
• W2529084725 cites W4242982898 @default.
• W2529084725 cites W4292329040 @default.
• W2529084725 doi "https://doi.org/10.1016/j.urology.2016.09.034" @default.
• W2529084725 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27720775" @default.
• W2529084725 hasPublicationYear "2017" @default.
• W2529084725 type Work @default.
• W2529084725 sameAs 2529084725 @default.
• W2529084725 citedByCount "12" @default.
• W2529084725 countsByYear W25290847252019 @default.
• W2529084725 countsByYear W25290847252020 @default.
• W2529084725 countsByYear W25290847252021 @default.
• W2529084725 countsByYear W25290847252022 @default.
• W2529084725 countsByYear W25290847252023 @default.
• W2529084725 crossrefType "journal-article" @default.
• W2529084725 hasAuthorship W2529084725A5006595036 @default.
• W2529084725 hasAuthorship W2529084725A5008621850 @default.
• W2529084725 hasAuthorship W2529084725A5017941913 @default.
• W2529084725 hasAuthorship W2529084725A5038206854 @default.
• W2529084725 hasAuthorship W2529084725A5055494457 @default.
• W2529084725 hasAuthorship W2529084725A5090882064 @default.
• W2529084725 hasConcept C126322002 @default.
• W2529084725 hasConcept C141071460 @default.
• W2529084725 hasConcept C2776301958 @default.
• W2529084725 hasConcept C2776664737 @default.
• W2529084725 hasConcept C2778661090 @default.
• W2529084725 hasConcept C2778810321 @default.
• W2529084725 hasConcept C2779161974 @default.
• W2529084725 hasConcept C2780653459 @default.
• W2529084725 hasConcept C31174226 @default.
• W2529084725 hasConcept C42219234 @default.
• W2529084725 hasConcept C71924100 @default.
• W2529084725 hasConceptScore W2529084725C126322002 @default.
• W2529084725 hasConceptScore W2529084725C141071460 @default.
• W2529084725 hasConceptScore W2529084725C2776301958 @default.
• W2529084725 hasConceptScore W2529084725C2776664737 @default.
• W2529084725 hasConceptScore W2529084725C2778661090 @default.
• W2529084725 hasConceptScore W2529084725C2778810321 @default.
• W2529084725 hasConceptScore W2529084725C2779161974 @default.
• W2529084725 hasConceptScore W2529084725C2780653459 @default.
• W2529084725 hasConceptScore W2529084725C31174226 @default.
• W2529084725 hasConceptScore W2529084725C42219234 @default.
• W2529084725 hasConceptScore W2529084725C71924100 @default.
• W2529084725 hasLocation W25290847251 @default.
• W2529084725 hasLocation W25290847252 @default.
• W2529084725 hasOpenAccess W2529084725 @default.
• W2529084725 hasPrimaryLocation W25290847251 @default.
• W2529084725 hasRelatedWork W1568966348 @default.
• W2529084725 hasRelatedWork W2515183968 @default.
• W2529084725 hasRelatedWork W2554174230 @default.
• W2529084725 hasRelatedWork W2582505536 @default.
• W2529084725 hasRelatedWork W2603244127 @default.
• W2529084725 hasRelatedWork W2609267468 @default.
• W2529084725 hasRelatedWork W2736631472 @default.
• W2529084725 hasRelatedWork W2779906290 @default.
• W2529084725 hasRelatedWork W2785204660 @default.
• W2529084725 hasRelatedWork W1570353559 @default.
• W2529084725 hasVolume "100" @default.
• W2529084725 isParatext "false" @default.
• W2529084725 isRetracted "false" @default.
• W2529084725 magId "2529084725" @default.
• W2529084725 workType "article" @default.